Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats

Food and Chemical Toxicology

Volumn 48, Issue 5, 2010, Pages 1178-1184

  Elberry, Ahmed A ^a   Abdel Naim, Ashraf B ^a   Abdel Sattar, Essam A ^a   Nagy, Ayman A ^b   Mosli, Hisham A ^b   Mohamadin, Ahmed M ^c   Ashour, Osama M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b King Abdulaziz University   (Saudi Arabia)

^c TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidation; Cardiotoxicity; Cranberry; Doxorubicin

Indexed keywords

CATALASE; CRANBERRY EXTRACT; CREATINE KINASE; CREATINE KINASE MB; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CRANBERRY; CREATINE KINASE BLOOD LEVEL; DRUG MECHANISM; DRUG SCREENING; ELECTROCARDIOGRAM; ENZYME ACTIVITY; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; DOXORUBICIN; ENZYMES; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEART; HEART DISEASES; MALE; MALONDIALDEHYDE; MYOCARDIUM; OXIDATIVE STRESS; OXIDOREDUCTASES; PLANT EXTRACTS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; TROPONIN I; VACCINIUM MACROCARPON;

RATTUS; VACCINIUM MACROCARPON;

EID: 77951647379     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.02.008     Document Type: Article

References (68)

1. Adams J., Lauterburg B., Mitchell J. Plasma glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J. Pharmacol. Exp. Ther. 1983, 227:749-754.
2. Aebi H. Catalase in vitro. Methods in Enzymology 1984, vol. 105:121-126. Academic Press, New York.
3. Ahmed H.H., Mannaa F., Elmegeed G.A., Doss S.H. Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity. Bioorg. Med. Chem. 2005, 13(5):1847-1857.
4. Ariga T. The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors 2004, 21:197-201.
5. Arnhold J., Osipov A.N., Spalteholz H., Panasenko O.M., Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radical Biol. Med. 2001, 31(9):1111-1119.
6. Aruoma O.I. Nutrition and health aspects of free radicals and antioxidants. Food Chem. Toxicol. 1994, 32:671-683.
7. Bagchi D., Sen C.K., Bagchi M., Atalay M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc) 2004, 69:75-80.
8. Bauer B.A. Herbal therapy: what a clinician needs to know to counsel patients effectively. Mayo Clin. Proc. 2000, 75:835-841.
9. Buzdar A.U., Marcus C., Smith T.L., Blumenschein G.R. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 1985, 55(12):2761-2765.
10. Busserolles J., Gueux E., Balasińska B., Piriou Y., Rock E., Rayssiguier Y., Mazur A. In vivo antioxidant activity of procyanidin-rich extracts from grape seed and pine (Pinus maritima) bark in rats. Int. J. Vitam. Nutr. Res. 2006, 76:22-27.
11. Chang W.T., Shao Z.H., Yin J.J., Mehendale S., Wang C.Z., Qin Y., Li J., Chen W.J., Chien C.T., Becker L.B., Vanden-Hoek T.L., Yuan C.S. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur. J. Pharmacol. 2007, 566:58-66.
12. Choi E.H., Lee N., Kim H.J., Kim M.K., Chi S., Kwon D.Y., Chun H.S. Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes. Genes Nutr. 2008, 2:337-345.
13. Cunningham D.G., Vannozzi S.A., Turk R., Roderick R., O'Shea E., Brilliant K. Cranberry phytochemicals and their health benefits. Nutraceutical Beverages: Chemistry, Nutrition, and Health Effects, ACS Symposium Series 871 2004, 35-51. American Chemical Society, Washington, DC. F. Shahidi, D.K. Weerasinghe (Eds.).
14. Dbrowska K., Stuss M., Gromadzińska J., Wasowicz W., Sewerynek E. The effects of melatonin on glutathione peroxidase activity in serum and erythrocytes after adriamycin in normal and pinealectomised rats. Endokrinol. Pol. 2008, 59(3):200-206.
15. De Beer E.L., Bottone A.E., Voest E.E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur. J. Pharmacol. 2001, 415:1-11.
16. de Rezende A.A., Graf U., Guterres Zda R., Kerr W.E., Spanó M.A. Protective effects of proanthocyanidins of grape (Vitis vinifera L.) seeds on DNA damage induced by doxorubicin in somatic cells of Drosophila melanogaster. Food Chem. Toxicol. 2009, 47:1466-1472.
17. den Hartog G.J., Haenen G.R., Boven E., wan der Vijgh W.J., Bast A. Lecithinized copper, zinc-superoxide dismutase as a protector against doxorubicin-induced cardiotoxicity in mice. Toxicol. Appl. Pharmacol. 2004, 194:180-188.
18. Doroshow J.H. Doxorubicin-induced cardiotoxicity. N. Engl. J. Med. 1991, 324:843-845.
19. Fadillioglu E., Oztas E., Erdogan H., Yagmurca M., Sogut S., Ucar M., Irmak M.K. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J. Appl. Toxicol. 2004, 24:47-52.
20. Foo L.Y., Lu Y., Howell A.B., Vorsa N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J. Nat. Prod. 2000, 63:1225-1228.
21. Hamza A., Amin A., Daoud S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol. Toxicol. 2008, 24(1):63-73.
22. Harborne J.B., Williams C.A. Anthocyanins and other flavonoids. Nat. Prod. Rep. 2001, 18:310-333.
23. Hayward R., Hydock D.S. Doxorubicin cardiotoxicity in the rat: an in vivo characterization. J. Am. Assoc. Lab. Anim. Sci. 2007, 46(4):20-32.
24. Herman E., Mhatre R., Lee I.P., Vick J., Waravdekar V.S. A comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys. Pharmacology 1971, 6:230-241.
25. Hissin P.J., Hilf R.A. Afluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
26. Ibrahim M.A., Ashour O.M., Ibrahim Y.F., El-Bitar H.I., Gomaa W., Abdel-Rahim S.R. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacol. Res. 2009, 60(5):373-381.
27. Iqbal M., Dubey K., Anwer T., Ashish A., Pillai K.K. Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats. Pharmacol. Rep. 2008, 60(3):382-390.
28. Jensen R.A., Acton E.M., Peters J.H. Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects. J. Cardiovasc. Pharmacol. 1984, 6:186-200.
29. Kang Y.J., Chen Y., Epstein P.N. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 1996, 271:12610-12616.
30. Kelishomi R.B., Ejtemaeemehr S., Tvangar S.M., Rahimian R., Mobarakeh J.I., Dehpour A.R. Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology 2008, 243:96-104.
31. Kim C., Kim N., Joo H., Youm J.B., Park W.S., Cuong D.V., Park Y.S., Kim E., Min C.K., Han J. Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin. J. Cardiovasc. Pharmacol. 2005, 46(2):200-210.
32. Kim Y., Ma A.G., Kitta K., Fitch S.N., Ikeda T., Ihara Y., Simon A.R., Evans T., Suzuki Y.J. Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol. Pharmacol. 2003, 63:368-377.
33. Kresty L.A., Morse M.A., Morgan C., Carlton P.S., Lu J., Gupta A., Blackwood M., Stoner G.D. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 2001, 61:6112-6119.
34. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shalteil S., Stantman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, V 186, Oxygen Radicals in Biological Systems 1990, 464-478. Academic Press, New York. L. Packer, A.N. Glazer (Eds.).
35. Li T., Singal P.K. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 2000, 102:2105-2110.
36. Li W., Xu B., Xu J., Wu X.L. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Basic Clin. Pharmacol. Toxicol. 2009, 104:192-197.
37. Liu X., Chen Z., Chua C.C., Ma Y.S., Youngberg G.A., Hamdy R., Chua B.H. Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H254-H263.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
39. Malisza K.L., Hasinoff B.B. Production of hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the xanthine oxidase/hypoxanthine system. Arch. Biochem. Biophys. 1995, 321:51-60.
40. Mihm M.J., Yu F., Weinstein D.M., Reiser P.J., Bauer J.A. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br. J. Pharmacol. 2002, 135:581-588.
41. Morishima I., Matsui H., Mukawa H., Hayashi K., Yukio T., Okumura K., Ito T., Hayukawa T. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Life Sci. 1998, 63:511-521.
42. Mukherjee S., Banerjee S.K., Maulik M., Dinda A.K., Talwar K.K., Maulik S.K. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression. BMC Pharmacol. 2003, 3:16.
43. Nazeyrollas P., Prévost A., Baccard N., Manot L., Devillier P., Millart H. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity. Cancer Chemother. Pharmacol. 1999, 43:227-232.
44. Ofek I., Goldhar J., Zafriri D., Lis H., Adar R., Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N. Engl. J. Med. 1991, 324(22):1599.
45. Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 1990, 4:3076-3086.
46. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
47. Peng X., Chen B., Lim C.C., Sawyer D.B. The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine. Mol. Interv. 2005, 5(3):163-171.
48. Puri A., Maulik S.K., Ray R., Bhatnagar V. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats. Eur. J. Pediatr. Surg. 2005, 15:387-391.
49. Riad A., Bien S., Westermann D., Becher P.M., Loya K., Landmesser U., Kroemer H.K., Schultheiss H.P., Tschöpe C. Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice. Cancer Res. 2009, 69(2):695-699.
50. Saad S.Y., Najjar T.A., Ai-Rikabi A.C. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol. Res. 2001, 43:211-218.
51. Shi R., Liu L., Huo Y., Cheng Y.Y. Study on protective effects of Panax notoginseng saponins on doxorubicin-induced myocardial damage. Zhongguo Zhong Yao Za Zhi 2007, 32(24):2632-2635.
52. Shuai Y.I., Guo I.B., Peng S.-G., Zhang L.-S., Guo J., Han G., Shen Dong Y. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment. Toxicol. Lett. 2007, 170(11):66-74.
53. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 1998, 339:900-905.
54. Siveski-Iliskovic N., Kaul N., Singal P.K. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994, 89:2829-2835.
55. Siveski-Iliskovic N., Hill M., Chow D.A., Singal P.K. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995, 91:10-15.
56. Staal G.E., Visser J., Veeger C. Purification and properties of glutathione reductase of human erythrocytes. Biochim. Biophys. Acta 1969, 185:39-48.
57. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
58. Takemura G., Fujiwara H. Doxorubicin-induced cardiomyopathy from Cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 2007, 49:330-352.
59. Tatlidede E., Sehirli O., Velioĝlu-Oĝünc A., Cetinel S., Yeĝen B.C., Yarat A., Süleymanoĝlu S., Sener G. Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radical Res. 2009, 43:195-205.
60. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
61. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharmacol. 1998, 124:425-427.
62. Vinson J.A., Su X., Zubik L., Bose P. Phenol antioxidant quantity and quality in foods: fruits. J. Agric. Food Chem. 2001, 49(11):5315-5321.
63. Wei H., Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993, 14:1195-1201.
64. Willett W.C. Diet, nutrition, and avoidable cancer. Environ. Health Perspect. 1995, 103(l8):165-170.
65. Xin Y.F., Zhou G.L., Shen M., Chen Y.X., Liu S.P., Chen G.C., Chen H., You Z.Q., Xuan Y.X. Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity. Basic Clin. Pharmacol. Toxicol. 2007, 101:421-426.
66. Xiong Y., Liu X., Lee C.P., Chua B.H., Ho Y.S. Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase. Free Radical Biol. Med. 2006, 41:46-55.
67. Yen H.C., Oberley T.D., Vichitbandha S., Ho Y.S., St Clair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 1996, 98:1253-1260.
68. 2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the side chain hydroxyl group. Biochim. Biophys. Acta 1986, 884:326-336.